デジタルPCR（dPCR）及び定量PCR（qPCR）の世界市場：装置、試薬、ソフトウェア...市場調査レポートについてご紹介

1 Introduction (Page No. – 14)
1.1 Study Objectives
1.2 digital PCR Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 digital PCR Market Stakeholders

2 Research Methodology (Page No. – 17)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Factor Analysis
2.2.1 Introduction
2.2.2 Demand-Side Analysis
2.2.2.1 Healthcare Expenditure Patterns
2.2.2.2 Rapid Growth of Aging Population
2.2.2.3 Incidence and Prevalence of Cancer
2.2.2.4 Birth Rate/Pregnancies
2.2.2.5 Burden of Infectious Diseases
2.2.2.6 Number of Clinical, Forensics, and Research Laboratories
2.2.3 Supply-Side Analysis
2.2.3.1 Number of New Product Launches: qPCR and dPCR vs Competitive Technologies
2.2.3.2 Parent Market Analysis: Polymerase Chain Reaction (PCR) Market
2.3 digital PCR Market Size Estimation
2.3.1 Top-Down Approach
2.3.2 Bottom-Up Approach
2.4 digital PCR Market Breakdown and Data Triangulation
2.5 Research Assumptions
2.5.1 Assumptions

3 Executive Summary (Page No. – 35)
3.1 Introduction
3.2 History, Evolution, and Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 41)
4.1 Global Digital PCR Market (2016-2021)
4.2 Global Digital PCR Technology Market, By Region (2016–2021)
4.3 Global Digital PCR Market Share, By Product and Service (2016)
4.4 Global Digital PCR Market Share, By Application (2016)
4.5 Global Digital PCR Market Share, By End User (2016–2021)

5 Market Overview (Page No. – 46)
5.1 Introduction
5.2 Technological Evolution in qPCR/dPCR
5.3 Digital PCR Market Segmentation
5.4 Digital PCR Market Dynamics
5.4.1 Drivers
5.4.1.1 Rising Incidences of Infectious Diseases and Genetic Disorders
5.4.1.2 Growing Geriatric Population
5.4.1.3 Technological Advancements
5.4.1.4 Increasing Public–Private Investments, Funds, and Grants
5.4.1.5 Rise in the Number of Hospitals and Diagnostics Centers
5.4.1.6 Successful Completion of the Human Genome Project
5.4.2 Restraints
5.4.2.1 High Device Costs Associated With dPCR
5.4.2.2 Technical Limitations of qPCR and dPCR Techniques
5.4.3 Opportunities
5.4.3.1 Growing Market Penetration in Emerging Countries
5.4.3.2 Shift From Plant-Derived to Genome-Based Drug Discovery
5.4.4 Challenges
5.4.4.1 Adoption and Implementation of Miqe Guidelines for Publishing qPCR and dPCR-Based Research

6 Industry Trends (Page No. – 57)
6.1 Introduction
6.2 Value Chain Analysis
6.3 Supply Chain Analysis
6.4 Industry Trends
6.4.1 Development of Lab-On-Chip PCR Devices
6.4.2 Ongoing Technological Integration With PCR Process
6.5 Porter’s Five Forces Analysis
6.5.1 Real-Time PCR (qPCR) Market: Porter’s Five Forces Analysis
6.5.1.1 Threat From New Entrants
6.5.1.2 Threat From Substitutes
6.5.1.3 Bargaining Power of Suppliers
6.5.1.4 Bargaining Power of Buyers
6.5.1.5 Intensity of Competitive Rivalry
6.5.2 Digital PCR Market: Porter’s Five Forces Analysis
6.5.2.1 Threat From New Entrants
6.5.2.2 Threat From Substitutes
6.5.2.3 Bargaining Power of Suppliers
6.5.2.4 Bargaining Power of Buyers
6.5.2.5 Intensity of Competitive Rivalry

7 Global qPCR and dPCR Market, By Technology (Page No. – 65)
7.1 Introduction
7.2 Quantitative PCR (qPCR)
7.3 Digital PCR (dPCR)

8 Global qPCR and dPCR Market, By Product and Service (Page No. – 69)
8.1 Introduction
8.2 qPCR Product and Services
8.2.1 qPCR Reagents and Consumables
8.2.2 qPCR Instruments
8.2.3 qPCR Software and Services
8.3 dPCR Product and Services
8.3.1 dPCR Instruments
8.3.2 dPCR Reagents and Consumables
8.3.3 dPCR Software and Services

9 qPCR and dPCR Market, By Application (Page No. – 77)
9.1 Introduction
9.2 qPCR
9.2.1 Clinical Applications
9.2.2 Research Applications
9.2.3 Forensic Applications
9.3 dPCR
9.3.1 Clinical Applications
9.3.2 Research Applications
9.3.3 Forensic Applications

10 qPCR and dPCR Market, By End User (Page No. – 85)
10.1 Introduction
10.2 Quantitative PCR (qPCR) End Users
10.2.1 Hospitals and Diagnostic Centers
10.2.2 Research Laboratories and Academic Institutes
10.2.3 Pharmaceutical and Biotechnology Companies
10.2.4 Clinical Research Organizations
10.2.5 Forensic Laboratories
10.3 Digital PCR (dPCR) End Users
10.3.1 Research Laboratories and Academic Institutes
10.3.2 Hospitals and Diagnostic Centers
10.3.3 Pharmaceutical and Biotechnology Companies
10.3.4 Clinical Research Organizations
10.3.5 Forensic Laboratories

11 qPCR and dPCR Market, By Region (Page No. – 97)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.3 Europe
11.4 Asia-Pacific
11.5 Rest of the World (RoW)

12 Competitive Landscape (Page No. – 119)
12.1 Overview
12.2 Digital PCR Market Share Analysis
12.2.1 qPCR Market Share Analysis (2015)
12.2.2 Digital PCR Share Analysis (2015)
12.3 Competitive Scenario
12.4 Recent Developments
12.4.1 New Product Launches and Product Enhancements
12.4.2 Agreements, Partnerships, and Collaborations
12.4.3 Mergers and Acquisitions
12.4.4 Geographical Expansions
12.4.5 Other Developments

13 Company Profiles (Page No. – 128)
13.1 Introduction
13.1.1 Geographic Benchmarking
13.1.2 Strategic Benchmarking
13.1.2.1 Product Development and Commercialization
13.2 Thermo Fisher Scientific, Inc.
13.2.1 Business Overview
13.2.2 Products & Services
13.2.3 Recent Developments
13.2.4 MnM Overview
13.3 Bio-Rad Laboratories, Inc.
13.3.1 Business Overview
13.3.2 Products & Services
13.3.3 Recent Developments
13.3.4 MnM Overview
13.4 F. Hoffman-LA Roche Ltd.
13.4.1 Business Overview
13.4.2 Products & Services
13.4.3 Recent Developments
13.4.4 MnM Overview
13.5 Qiagen N.V.
13.5.1 Business Overview
13.5.2 Products Offered
13.5.3 Recent Developments
13.5.4 MnM Overview
13.6 Agilent Technologies, Inc.
13.6.1 Business Overview
13.6.2 Products Offered
13.6.3 Recent Developments
13.6.4 MnM Overview
13.7 Takara Bio, Inc.
13.7.1 Business Overview
13.7.2 Products Offered
13.7.3 Recent Developments
13.8 Biomérieux S.A.
13.8.1 Business Overview
13.8.2 Products & Services
13.8.3 Recent Developments
13.9 Affymetrix, Inc.
13.9.1 Business Overview
13.9.2 Products Offered
13.9.3 Recent Developments
13.10 Fluidigm Corporation
13.10.1 Business Overview
13.10.2 Products Offered
13.10.3 Recent Developments
13.11 Raindance Technologies, Inc.
13.11.1 Business Overview
13.11.2 Products and Services
13.11.3 Recent Developments

14 Appendix (Page No. – 171)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Introducing RT: Real-Time Market Intelligence
14.4 Available Customizations
14.5 Related Reports